Thousands of men with prostate cancer are set to benefit from access to a life‑extending drug on the NHS, after ...

A phase Ib/II study (IMMCO-1) of atezolizumab plus tivozanib in castrate-resistant prostate cancer and certain other immunologically cold tumors. Background: Androgen deprivation therapy (ADT) with ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Onco360 ®, the nation’s leading independent Specialty Pharmacy, has been selected by Myovant Sciences to be a specialty pharmacy partner for ORGOVYX ® (relugolix), ...

The NHS will provide a life-extending prostate cancer drug to men in England, expanding access to a treatment proven to ...

Acute bowel symptoms following relugolix and stereotactic body radiotherapy for localized prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

Prostate cancer treatment is advancing rapidly. New pills and hormone treatments are giving patients better odds and a more comfortable experience. Doctors say Biden's diagnosis is a reminder to get ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...